BackVYNE Therapeutics Overview

VYNE Therapeutics Accounts Payable

VYNE Therapeutics's accounts payable is $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer average / median

Loading

VYNE Therapeutics Accounts Payable History

Loading

VYNE Therapeutics vs. peers: Accounts Payable Comparison

Loading

VYNE Therapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

VYNE Therapeutics (VYNE) FAQ

VYNE Therapeutics (VYNE) currently reports a accounts payable of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore VYNE Therapeutics's accounts payable history and peer comparisons.

VYNE Therapeutics's accounts payable changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

VYNE Therapeutics reported $0 in accounts payable as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for VYNE Therapeutics, and consider following VYNE for alerts when major investors trade the stock.

VYNE Therapeutics is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VYNE with unrelated industries.